Virtu Financial LLC Sells 9,884 Shares of Cryoport, Inc. (NASDAQ:CYRX)

Virtu Financial LLC lowered its position in Cryoport, Inc. (NASDAQ:CYRX) by 33.9% in the 3rd quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 19,257 shares of the company’s stock after selling 9,884 shares during the period. Virtu Financial LLC’s holdings in Cryoport were worth $156,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently made changes to their positions in the company. SG Americas Securities LLC purchased a new stake in shares of Cryoport in the 2nd quarter worth about $185,000. Bank of New York Mellon Corp increased its position in Cryoport by 13.3% during the 2nd quarter. Bank of New York Mellon Corp now owns 169,155 shares of the company’s stock valued at $1,169,000 after buying an additional 19,803 shares in the last quarter. Rhumbline Advisers raised its stake in Cryoport by 3.4% during the second quarter. Rhumbline Advisers now owns 64,158 shares of the company’s stock valued at $443,000 after buying an additional 2,086 shares during the last quarter. Quest Partners LLC boosted its holdings in Cryoport by 1,083,000.0% in the second quarter. Quest Partners LLC now owns 10,831 shares of the company’s stock worth $75,000 after acquiring an additional 10,830 shares in the last quarter. Finally, NRI Wealth Management LC purchased a new stake in shares of Cryoport in the second quarter worth $132,000. Hedge funds and other institutional investors own 92.90% of the company’s stock.

Analyst Ratings Changes

CYRX has been the subject of several recent analyst reports. UBS Group lifted their target price on shares of Cryoport from $7.00 to $9.00 and gave the stock a “neutral” rating in a report on Friday, October 18th. Roth Mkm dropped their price objective on Cryoport from $18.00 to $15.00 and set a “buy” rating on the stock in a research report on Friday, November 8th. Three research analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $12.50.

Cryoport Price Performance

NASDAQ CYRX opened at $7.79 on Thursday. Cryoport, Inc. has a 52 week low of $5.32 and a 52 week high of $20.10. The company has a 50-day moving average price of $7.33 and a 200-day moving average price of $8.04. The firm has a market capitalization of $385.07 million, a P/E ratio of -2.30 and a beta of 1.62. The company has a quick ratio of 5.32, a current ratio of 5.70 and a debt-to-equity ratio of 0.48.

Insiders Place Their Bets

In other news, CEO Jerrell Shelton sold 50,000 shares of the stock in a transaction on Thursday, November 21st. The shares were sold at an average price of $6.51, for a total value of $325,500.00. Following the completion of the sale, the chief executive officer now directly owns 731,897 shares of the company’s stock, valued at $4,764,649.47. This represents a 6.39 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Ramkumar Mandalam sold 7,369 shares of Cryoport stock in a transaction on Monday, December 2nd. The shares were sold at an average price of $7.46, for a total transaction of $54,972.74. Following the transaction, the director now owns 59,497 shares in the company, valued at approximately $443,847.62. This trade represents a 11.02 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 109,869 shares of company stock worth $735,673 over the last quarter. 10.10% of the stock is currently owned by corporate insiders.

Cryoport Company Profile

Cryoport, Inc provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and human reproductive medicine markets in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Cryoport Express Shippers; Cryoport ELITE -80°C Gene Therapy Shipper; Cryoport ELITE Cryosphere Shipper; Cryoport consulting services, including physical, thermal, and shipping qualifications of shipping systems and/or packaging to developing custom packaging solutions; and Cryoport bioservices, such as controlled temperature storage, fulfilment, kit production, secondary packaging, labelling of therapeutic products, and GMP raw materials storage services.